We are live on ! Find out more
EVGN icon

Evogene
EVGN

17 hedge funds and large institutions have $15.2M invested in Evogene in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $15.2M → $15.2M (+$20K)

0% less ownership

Funds ownership: 2.92% → 2.92% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

6% less funds holding

Funds holding: 18 → 17 (-1)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$30.5K
2
MIH
Meitav Investment House
Israel
+$28.5K
3
Jane Street
Jane Street
New York
+$10.9K
4
AIM
ARK Investment Management
Florida
+$9.85K

Top Sellers

Rank Fund Capital Flow
1
EVC
Eidelman Virant Capital
Missouri
-$102K
2
UBS Group
UBS Group
Switzerland
-$54.4K
3
Morgan Stanley
Morgan Stanley
New York
-$15.7K
4
Barclays
Barclays
United Kingdom
-$456
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$4.42M – – –
JP Morgan Chase
2
JP Morgan Chase
New York
$3.68M – – –
UBS Group
3
UBS Group
Switzerland
$2.23M -$54.4K -3,459 -2%
Goldman Sachs
4
Goldman Sachs
New York
$1.21M – – –
CI
5
Clal Insurance
Israel
$934K – – –
SM
6
Senvest Management
New York
$655K – – –
MCM
7
Moon Capital Management
New York
$578K – – –
Bank of America
8
Bank of America
North Carolina
$514K – – –
PF
9
Phoenix Financial
Israel
$397K +$414K +26,313 New
AIM
10
ARK Investment Management
Florida
$331K +$9.85K +626 +3%
MIH
11
Meitav Investment House
Israel
$121K +$28.5K +1,811 +34%
Jane Street
12
Jane Street
New York
$56K +$10.9K +690 +24%
Citadel Advisors
13
Citadel Advisors
Florida
$31K +$30.5K +1,938 New
Morgan Stanley
14
Morgan Stanley
New York
$16K -$15.7K -1,000 -50%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$16K – – –
Citigroup
16
Citigroup
New York
$13K – – –
Barclays
17
Barclays
United Kingdom
$1K -$456 -29 -29%
EVC
18
Eidelman Virant Capital
Missouri
– -$102K -6,360 Closed

EVGN Hedge Fund Activity: Q3 2019 in Review

17 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2019, worth a combined $15.2M — up 0.13% from $15.2M a quarter earlier.

Fund positioning in EVGN was balanced in Q3 2019: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $30.5K. The largest seller was Eidelman Virant Capital, exiting entirely with an estimated $102K sold.

  • 17 institutional investors held Evogene (EVGN) as of Q3 2019, down from 18 in Q2 2019.
  • Funds reported $15.2M of Evogene stock for Q3 2019, up 0.13% quarter-over-quarter.
  • 2 funds opened new Evogene positions in Q3 2019 and 2 closed out, a net change of 0 holders.
  • The largest Evogene buyer in Q3 2019 was Citadel Advisors, an estimated $30.5K added.
  • The largest Evogene seller in Q3 2019 was Eidelman Virant Capital, an estimated $102K sold.

Based on aggregated 13F filings for Q3 2019.